Global Intracranial Aneurysm Market: By Type: Ruptured Aneurysms, Unruptured Aneurysms; By Treatment: Surgical Clipping, Endovascular Coiling, Flow Diversion, Others (Balloon-assisted, Stent-assisted); By End User: Hospitals, Specialty Neurology & Neurosurgery Centers, Ambulatory Surgical Centers; By Region: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.
1 | Market Overview
The global intracranial aneurysm market is advancing steadily, driven by the increasing incidence of subarachnoid hemorrhage (SAH), technological advancements in neurointervention, and a growing adoption of preventive screening. Intracranial aneurysms—abnormal bulges in the brain's blood vessels—can be life-threatening when ruptured and often require urgent or elective treatment through coiling, clipping, or flow diversion.
Minimally invasive neurovascular techniques, such as endovascular coiling and stent-assisted treatments, have revolutionized aneurysm management by enhancing patient outcomes and shortening recovery times. Innovations in embolic coils, detachable microcatheters, and flow-diverting stents are broadening therapeutic options worldwide.
2 | Market Size and Forecast
|
Year |
Market Value (USD Billion) |
Notes |
|
2019 |
1.26 |
Historical benchmark |
|
2024 |
1.91 |
Five-year CAGR 8.7% |
|
2031 |
3.65 |
Seven-year CAGR 9.6% |
The market is expected to nearly double between 2024 and 2031, led by early detection, rapid expansion of endovascular techniques, and growing surgical case volumes in developing economies.
3 | Key Market Drivers
4 | Market Challenges
5 | Competitive Landscape
The market is consolidated among leading neurovascular firms that offer advanced devices for managing both ruptured and unruptured aneurysms.
Market Share Estimates (2024):
|
Company |
Estimated Market Share |
Key Products |
|
Stryker |
29% |
Target® coils, Neuroform Atlas® stents |
|
Medtronic |
24% |
Pipeline® Embolization Devices (PED), Axium™ coils |
|
MicroVention (Terumo) |
19% |
HydroCoil®, LVIS™ stents, WEB™ embolization system |
|
Penumbra Inc. |
10% |
SMART™ coils, 3D revascularization tools |
|
Others (Phenox, Balt, Cerus Endovascular) |
18% |
Niche and innovative embolization devices |
6 | Market Segmentation
By Type:
By Treatment:
By End User:
By Region:
7 | Strategic Outlook
The future of aneurysm treatment lies in bifurcation-specific devices, radiopaque coils, AI-assisted imaging, and next-generation flow diversion platforms. Public screening programs, value-based pricing models, and integrated neurovascular care systems will further accelerate global adoption.
Need help?
Chat with our team in a minute.